ロード中...
Potential for treatment of severe autism in tuberous sclerosis complex
The Food and Drug Administration (FDA) has approved two mechanism-based treatments for tuberous sclerosis complex (TSC)-everolimus and vigabatrin. However, these treatments have not been systematically studied in individuals with TSC and severe autism. The aim of this review is to identify the clini...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4145642/ https://ncbi.nlm.nih.gov/pubmed/25254170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5409/wjcp.v2.i3.16 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|